La Trobe

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer

Download (1.46 MB)
journal contribution
posted on 2023-04-12, 01:33 authored by Higinio Dopeso, Paulo Rodrigues, Josipa Bilic, Sarah Bazzocco, Fernando Carton-Garcia, Irati Macaya, Priscila Guimaraes de Marcondes, Estefania Anguita, Marc Masanas, Lizbeth M Jimenez-Flores, Augueda Martinez-Barriocanal, Rocio Nieto, Miguel F Segura, Simo Schwartz, John MariadasonJohn Mariadason, Diego Arango

Background: Reduced RHOA signalling has been shown to increase the growth/metastatic potential of colorectal tumours. However, the mechanisms of inactivation of RHOA signalling in colon cancer have not been characterised.Methods:A panel of colorectal cancer cell lines and large cohorts of primary tumours were used to investigate the expression and activity of RHOA, as well as the presence of RHOA mutations/deletions and promoter methylation affecting RHOA. Changes in RHOA expression were assessed by western blotting and qPCR after modulation of microRNAs, SMAD4 and c-MYC.Results:We show here that RHOA point mutations and promoter hypermethylation do not significantly contribute to the large variability of RHOA expression observed among colorectal tumours. However, RHOA copy number loss was observed in 16% of colorectal tumours and this was associated with reduced RHOA expression. Moreover, we show that miR-200a/b/429 downregulates RHOA in colorectal cancer cells. In addition, we found that TGF-β/SMAD4 upregulates the RHOA promoter. Conversely, RHOA expression is transcriptionally downregulated by canonical Wnt signalling through the Wnt target gene c-MYC that interferes with the binding of SP1 to the RHOA promoter in colon cancer cells.Conclusions:We demonstrate a complex pattern of inactivation of the tumour suppressor gene RHOA in colon cancer cells through genetic, transcriptional and post-transcriptional mechanisms.

Funding

This study was partially funded by grants of the Association for International Cancer Research (AICR13-0245), the Spanish Ministry for Economy and Competitiveness (CP05/00256, PI12/03103, PI12/01095, PI16/00540 and AC15/00066) and Asociacion Espanola contra el Cancer (AECC GCA15152966ARAN) to Diego Arango. Higinio Dopeso is supported by a Juan de la Cierva fellowship (JCI-2012-14357).

History

Publication Date

2018-01-01

Journal

British Journal of Cancer

Volume

118

Issue

1

Pagination

11p. (p. 106-116)

Publisher

Nature Publishing Group

ISSN

0007-0920

Rights Statement

© 2018 Cancer Research UK. This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/

Usage metrics

    Journal Articles

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC